News

FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
FDA still negotiating whether to grant full approval to Novavax COVID-19 vaccine
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
Stanford study: When measles could return if vaccination rates continue to fall
Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like ...
Novavax told by FDA to conduct additional study for COVID vaccine - report
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
A 6-hour morning routine? First, try a few simple habits to start your day
At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...
US FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports
(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
Novavax Slips After WSJ Report on FDA Request for Another Vaccine Study
Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...
Novavax asked by FDA to complete additional COVID trial, WSJ says
EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...
Novavax down 10% after WSJ report on FDA request for additional vaccine trial
EDT Novavax (NVAX) down 10% after WSJ report on FDA request for additional vaccine trialStay Ahead of the Market: Discover outperforming ...
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...